Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log
NCT03239886
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Myeloid, Chronic-Phase
Interventions
OTHER:
imatinib discontinuation
Sponsor
University of Sao Paulo General Hospital